| 1 | 1 | | FIRSTREGULARSESSION |
|---|
| 2 | 2 | | HOUSEBILLNO.929 |
|---|
| 3 | 3 | | 103RDGENERALASSEMBLY |
|---|
| 4 | 4 | | INTRODUCEDBYREPRESENTATIVESTINNETT. |
|---|
| 5 | 5 | | 2251H.01I JOSEPHENGLER,ChiefClerk |
|---|
| 6 | 6 | | ANACT |
|---|
| 7 | 7 | | Torepealsection336.010,RSMo,andtoenactinlieuthereofonenewsectionrelatingtothe |
|---|
| 8 | 8 | | practiceofoptometry. |
|---|
| 9 | 9 | | BeitenactedbytheGeneralAssemblyofthestateofMissouri,asfollows: |
|---|
| 10 | 10 | | SectionA.Section336.010,RSMo,isrepealedandonenewsectionenactedinlieu |
|---|
| 11 | 11 | | 2thereof,tobeknownassection336.010,toreadasfollows: |
|---|
| 12 | 12 | | 336.010.1.The"practiceofoptometry"istheexamination,diagnosis,[treatment, |
|---|
| 13 | 13 | | 2andpreventativecare]prevention,andtreatment,surgicalornonsurgical,oftheeye, |
|---|
| 14 | 14 | | 3adnexa,andvision.Thepracticeincludes,butisnotlimitedto: |
|---|
| 15 | 15 | | 4 (1)Theexaminationoftheeye,adnexa,andvisiontodeterminetheaccommodative |
|---|
| 16 | 16 | | 5andrefractivestates,visualperception,conditions,anddiseases; |
|---|
| 17 | 17 | | 6 (2)Thediagnosisandtreatmentofconditionsordiseasesoftheeye,adnexa,and |
|---|
| 18 | 18 | | 7vision; |
|---|
| 19 | 19 | | 8 (3)Theperformanceofdiagnosticproceduresandorderingoflaboratoryandimaging |
|---|
| 20 | 20 | | 9testsforthediagnosisofvisionandconditionsanddiseasesoftheeyeandadnexa; |
|---|
| 21 | 21 | | 10 (4)Theprescriptionandadministrationofpharmaceuticalagents[, excluding |
|---|
| 22 | 22 | | 11injectableagents,] forthepurposeofexamination,diagnosis,andtreatmentofvisionand |
|---|
| 23 | 23 | | 12conditionsordiseasesoftheeyeandadnexa; |
|---|
| 24 | 24 | | 13 (5)Theremovalofsuperficialforeignbodiesfromtheeyeoradnexa; |
|---|
| 25 | 25 | | 14 (6)Notwithstandingtheprovisionsofanyotherlawtothecontrary,including |
|---|
| 26 | 26 | | 15section334.010,thecorrectionandreliefofocularabnormalitiesbysurgicalprocedures |
|---|
| 27 | 27 | | 16notexcludedundersubsection2ofthissection; |
|---|
| 28 | 28 | | EXPLANATION—Matterenclosedinbold-facedbrackets[thus] intheabovebillisnotenactedandis |
|---|
| 29 | 29 | | intendedtobeomittedfromthelaw.Matterinbold-facetypeintheabovebillisproposedlanguage. 17 (7)Theemploymentofobjectiveorsubjectivemechanicalmeanstodeterminethe |
|---|
| 30 | 30 | | 18accommodativeorrefractivestatesofthehumaneye; |
|---|
| 31 | 31 | | 19 [(7)](8)Theprescriptionoradaptationoflenses,prisms,devices,orocularexercises |
|---|
| 32 | 32 | | 20tocorrectdefectsorabnormalconditionsofthehumaneyeorvisionortoadjustthehuman |
|---|
| 33 | 33 | | 21eyetospecialconditions; |
|---|
| 34 | 34 | | 22 [(8)](9)Theprescriptionandfittingofophthalmicorcontactlensesanddevices; |
|---|
| 35 | 35 | | 23 [(9)](10)Theprescriptionandadministrationofvisiontherapy;and |
|---|
| 36 | 36 | | 24 [(10)] (11)Theprescriptionandadministrationoflowvisioncare. |
|---|
| 37 | 37 | | 25 2.Theboardshallcontinuetoreviewsurgicalproceduresnotlistedinthis |
|---|
| 38 | 38 | | 26subsectionbutwhichshallbeexcludedfromthescopeofthepracticeofoptometry.The |
|---|
| 39 | 39 | | 27followingproceduresarenotwithinthescopeofoptometryandanoptometrist[may] |
|---|
| 40 | 40 | | 28shallnotperform[surgery,includingtheuseoflasersfortreatmentofanydiseaseor |
|---|
| 41 | 41 | | 29conditionorforthecorrectionofrefractiveerror] suchprocedures,exceptforthe |
|---|
| 42 | 42 | | 30preoperativeandpostoperativecareoftheseprocedures: |
|---|
| 43 | 43 | | 31 (1)Retinalaserprocedures,laser-assistedinsitukeratomileusis(LASIK),and |
|---|
| 44 | 44 | | 32photorefractivekeratectomy(PRK); |
|---|
| 45 | 45 | | 33 (2)Nonlasersurgeryrelatedtoremovaloftheeyefromalivinghumanbeing; |
|---|
| 46 | 46 | | 34 (3)Nonlasersurgeryrequiringfullthicknessincisionorexcisionofthecorneaor |
|---|
| 47 | 47 | | 35scleraotherthanparacentesisinanemergencysituationrequiringimmediatereduction |
|---|
| 48 | 48 | | 36ofthepressureinsidetheeye; |
|---|
| 49 | 49 | | 37 (4)Penetratingkeratoplasty(cornealtransplant)orlamellarkeratoplasty; |
|---|
| 50 | 50 | | 38 (5)Nonlasersurgeryrequiringincisionoftheirisandciliarybody,includingiris |
|---|
| 51 | 51 | | 39diathermyorcryotherapy; |
|---|
| 52 | 52 | | 40 (6)Nonlasersurgeryrequiringincisionofthevitreous; |
|---|
| 53 | 53 | | 41 (7)Nonlasersurgeryrequiringincisionoftheretina; |
|---|
| 54 | 54 | | 42 (8)Nonlasersurgicalextractionofthecrystallinelens; |
|---|
| 55 | 55 | | 43 (9)Nonlasersurgicalintraocularimplants; |
|---|
| 56 | 56 | | 44 (10)Incisionalorexcisionalnonlasersurgeryoftheextraocularmuscles; |
|---|
| 57 | 57 | | 45 (11)Nonlasersurgeryoftheeyelidforeyelidmalignanciesorforincisional |
|---|
| 58 | 58 | | 46cosmeticormechanicalrepairofblepharochalasis,ptosis,andtarsorrhaphy; |
|---|
| 59 | 59 | | 47 (12)Nonlasersurgeryofthebonyorbit,includingorbitalimplants; |
|---|
| 60 | 60 | | 48 (13)Incisionalorexcisionalnonlasersurgeryofthelacrimalsystemotherthan |
|---|
| 61 | 61 | | 49lacrimalprobingorrelatedprocedures; |
|---|
| 62 | 62 | | 50 (14)Nonlasersurgeryrequiringfullthicknessconjunctivoplastywithgraftor |
|---|
| 63 | 63 | | 51flap; |
|---|
| 64 | 64 | | 52 (15)Anynonlasersurgicalprocedurethatdoesnotprovideforthecorrection |
|---|
| 65 | 65 | | 53andreliefofocularabnormalities; |
|---|
| 66 | 66 | | HB929 2 54 (16)Laserornonlaserinjectionintotheposteriorchamberoftheeyetotreat |
|---|
| 67 | 67 | | 55anymacularorretinaldisease;and |
|---|
| 68 | 68 | | 56 (17)Theadministrationofgeneralanesthesia. |
|---|
| 69 | 69 | | 57 3.Asusedinthischapter,exceptasthecontextmayotherwiserequire,thefollowing |
|---|
| 70 | 70 | | 58termsmean: |
|---|
| 71 | 71 | | 59 (1)"Eye",thehumaneye; |
|---|
| 72 | 72 | | 60 (2)"Adnexa",allstructuresadjacenttotheeyeandtheconjunctiva,lids,lashes,and |
|---|
| 73 | 73 | | 61lacrimalsystem; |
|---|
| 74 | 74 | | 62 (3)"Board",theMissouristateboardofoptometry; |
|---|
| 75 | 75 | | 63 (4)"Diagnosticpharmaceuticalagents",topicallyappliedpharmaceuticalsusedfor |
|---|
| 76 | 76 | | 64thepurposeofconductinganexaminationoftheeye,adnexa,andvision; |
|---|
| 77 | 77 | | 65 (5)"Lowvisioncare",theexamination,treatment,andmanagementofpatientswith |
|---|
| 78 | 78 | | 66visualimpairmentsnottreatablebyconventionaleyewearorcontactlensesandmayincludea |
|---|
| 79 | 79 | | 67visionrehabilitationprogramtoenhanceremainingvisionskills; |
|---|
| 80 | 80 | | 68 (6)"Pharmaceuticalagents",anydiagnosticandtherapeuticdrugorcombinationof |
|---|
| 81 | 81 | | 69drugsthatassistthediagnosis,prevention,treatment,ormitigationofabnormalconditionsor |
|---|
| 82 | 82 | | 70symptomsofthehumaneye,adnexa,andvision; |
|---|
| 83 | 83 | | 71 (7)"Therapeuticpharmaceuticalagents",thosepharmaceuticals[, excluding |
|---|
| 84 | 84 | | 72injectableagents,] usedforthetreatmentofconditionsordiseasesoftheeye,adnexa,and |
|---|
| 85 | 85 | | 73vision; |
|---|
| 86 | 86 | | 74 (8)"Visiontherapy",atreatmentregimenttoimproveapatient'sdiagnosedvisual |
|---|
| 87 | 87 | | 75dysfunctions,preventthedevelopmentofvisualproblems,orenhancevisualperformanceto |
|---|
| 88 | 88 | | 76meetthedefinedneedsofthepatient. |
|---|
| 89 | 89 | | âś” |
|---|
| 90 | 90 | | HB929 3 |
|---|